HIF1A and metastatic neoplasm: While expression of HIF1α did not differ between the non-metastatic and bone-metastatic primary RCCs (p/mRNA/=0.252, p/protein/=0.385), HIF2α was found to be significantly lower both at mRNA and protein levels in the metastatic tumors (p/mRNA/=0.011, p/protein/=0.001) (Figures 1 and 2).